Can Behenic Acid (C22:0) Levels be a Prognostic Factor in Glial Tumors?

dc.contributor.authorKaplan, Metin
dc.contributor.authorKoparan, Mehmet
dc.contributor.authorSari, Aysel
dc.contributor.authorOzturk, Sait
dc.contributor.authorKaplan, Serpil Kozan
dc.contributor.authorErol, Fatih Serhat
dc.date.accessioned2026-08-12T17:15:15Z
dc.date.issued2013
dc.departmentFırat Üniversitesi
dc.description.abstractBackground: Inhibition of fatty acid synthase leads to apoptosis in cancers, which leads to high levels of fatty acid synthesis. This indicates that cancer cells depend on fatty acid in order to survive. In this study, we investigated whether or not there was a relationship between the glial tumor grade and free fatty acid level of tumor tissue. Methods: Twenty patients who had high grade glial tumors and 20 patients who had low grade glial tumors, were included in the study. Tumors samples were obtained intraoperatively in order to measure the fatty acid levels. The fatty acids were studied in three groups: saturated fatty acids, monounsaturated fatty acids and polyunsaturated fatty acids. They were analyzed with gas chromatography. Results: The oleic acid, linoleic acid, eicosadienoic acid, arachidonic acid, and docosadienoic acid levels were high in the tumor tissue of low grade tumors. The myristic acid, palmitic acid, stearic acid, alpha linoleic acid, eicosenoic acid, dihomo-gamma-linolenic acid, docosahexaenoic acid, and ceramide levels were high in the tumor tissue of high grade glial tumors. However, none of these high values were statistically significant. The high values of behenic acid, a saturated fatty acid, in low grade glial tumors were statistically significant. Conclusion: High levels of behenic acid in patients with low grade glial tumor is important as it indicates persistence of the tissue integrity and tissue resistance. behenic acid levels can be a prognostic factor in glial tumors.
dc.identifier.doi10.1017/S0317167100016012
dc.identifier.endpage856
dc.identifier.issn0317-1671
dc.identifier.issn2057-0155
dc.identifier.issue6
dc.identifier.orcid0000-0002-7655-0127
dc.identifier.pmid24257229
dc.identifier.scopus2-s2.0-84888261209
dc.identifier.scopusqualityQ2
dc.identifier.startpage854
dc.identifier.urihttps://doi.org/10.1017/S0317167100016012
dc.identifier.urihttps://hdl.handle.net/11508/52148
dc.identifier.volume40
dc.identifier.wosWOS:000209534800019
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherCambridge Univ Press
dc.relation.ispartofCanadian Journal of Neurological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.titleCan Behenic Acid (C22:0) Levels be a Prognostic Factor in Glial Tumors?
dc.typeArticle

Dosyalar